Cai et al. (2018) showed that METTL3 promotes breast cancer through inhibiting let-7g. Other studies also support that METTL3 plays a role in inflammatory response, rheumatoid arthritis, and cardiovascular disease (Song et al., 2019; Wang et al., 2019b). The gene discussed is METTL3; the disease is breast carcinoma.